Dr. Tajmir is a dual board-certified Diagnostic Radiology and Nuclear Medicine physician with advanced training in abdominal, musculoskeletal, and cardiac imaging.

He specializes in the use of advanced cross-sectional imaging techniques (CT, MR, PET/CT, PET/MR, SPECT) to non-invasively diagnose cancer, coronary artery disease, and musculoskeletal pathologies. He has a focus on PET/MR protocol development, previously clinical director of PET/MR at another large academic medical center where he developed the SuperPET concept in PET/MR.

Dr. Tajmir is also a member of the Theranostics team at MGH, offering Radium223 (Xofigo), Lutetium Dotatate (Lutathera), and Lutetium PSMA (Pluvicto) therapies for patients in New England.

His training includes a transitional residency at BIDMC/Signature Healthcare in Brockton, MA, followed by a combined Diagnostic Radiology/Nuclear Medicine residency at Massachusetts General Hospital in Boston, MA. He is board certified by the American Board of Radiology, American Board of Nuclear Medicine, and Certification Board of Cardiovascular Computed Tomography.

Dr. Tajmir has an interest in IT/Operations and serves as Director of MGH Nuclear Medicine IT. He currently is working to deploy machine learning algorithms into the MGH PACS environment and modernize the NMMI service lines at MGH/MGB.